Recon: FDA accepts Alvotech’s BLA for Humira biosimilar; Commission claims EU pharma revision will boost competitiveness
ReconJason Scott
APIsBiologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsDiagnostics/IVDsGlobalMedical DevicesNutritional/Natural HealthOTCOtherPharmaceuticals